RECENT PLACEMENT

Occam Places Mary Kay Fenton as CFO at Semma

Occam Places Mary Kay Fenton as CFO at Semma

Semma Therapeutics is a cell therapy company founded by Doug Melton of Harvard University and financed by ARCH Venture, MPM, and F-Prime. The company was subsequently acquired by Vertex for approximately $1B in late 2019.

In May 2019, Occam placed Mary Kay Fenton as CFO, having years of experience working with fast-growing biotech companies, most recently as EVP and CFO of Achillion Pharmaceuticals. With Fenton in place, Semma was subsequently acquired by Vertex for $1B.

‍

Recent Placements

  1. Avirup Bose, Ph.D., as Chief Business Officer of Iktos
  2. Steve Harrison as CSO at Nucleome
  3. Aimee Einstein as VP of People & Culture at SI-BONE
  4. David Brower as CBO for Oncology Biotech Accent Therapeutics
  5. Annette Matthies as CBO at Elicio Therapeutics
  6. Steve Staben as CSO at Lycia Therapeutics
About Occam Global

Occam Global is a trusted executive search, consulting, and investment partner for leaders and investors shaping the future of life sciences, deep tech, and venture capital. Since 2012, we’ve helped build high-performing teams and advised visionary companies from stealth to public markets. Our success stems from exceptional access to rare talent, deep sector expertise, and a commitment to results guided by elevated ethics and enlightened aggression.